Change Sets / Atorvastatin — move to Tier 2 and add Prior Authorization
Atorvastatin — move to Tier 2 and add Prior Authorization
in_review 2027 MA-PD Parent Formulary
Request details
Proposed parent-baseline change as part of the 2027 formulary strategy review.
Member impact summary
2 potentially member-impacting changesThese changes make the formulary more restrictive (higher tier, PA/ST added, tighter QL, or coverage removed) and warrant careful review.
Structured diff (normalized business facts, not file cells)
| Drug | Field changed | Old value | New value | Member impact | |
|---|---|---|---|---|---|
| atorvastatin calcium 40 MG Oral Tablet 617311 | Tier | 1 | → | 2 | Higher tier (1 → 2) |
| atorvastatin calcium 40 MG Oral Tablet 617311 | Prior Authorization (PA) | false | → | true | Prior Authorization added |
Review actions
Approving records a reviewer decision. Merging applies the diff to the formulary’s items and marks the change set merged.
Approval history
| Reviewer | Role | Decision | Comments | When |
|---|---|---|---|---|
| No decisions recorded yet. | ||||